Photo taken from Chordoma Foundation/X
Jul 14, 2024, 07:59
New drug from Erasca in combination with cetuximab – Chordoma Foundation
Chordoma Foundation shared a post on X:
“Promising results have emerged from a Phase 1 clinical trial testing a new drug from Erasca called ERAS-601 alone and in combination with cetuximab: Nearly all of the 13 chordoma patients enrolled had some tumor shrinkage.”
-
ESMO 2024 Congress
September 13-17, 2024
-
ASCO Annual Meeting
May 30 - June 4, 2024
-
Yvonne Award 2024
May 31, 2024
-
OncoThon 2024, Online
Feb. 15, 2024
-
Global Summit on War & Cancer 2023, Online
Dec. 14-16, 2023
Nov 14, 2024, 11:30
Nov 14, 2024, 09:31
Nov 14, 2024, 09:26
Nov 14, 2024, 09:21
Nov 14, 2024, 09:15
Nov 14, 2024, 00:19